Phenotyping Psychosocially High-Risk Rheumatoid Arthritis Patients Using Longitudinal Analyses and Development of Targeted Psychosocial Treatment Algorithms

Grants and Contracts Details

StatusActive
Effective start/end date5/26/201/1/23

Funding

  • Pfizer Inc.: $150,000.00